Lacklustre Performance Is Driving EROAD Limited's (NZSE:ERD) 34% Price Drop

To the annoyance of some shareholders, EROAD Limited (NZSE:ERD) shares are down a considerable 34% in the last month, which continues a horrid run for the company. Looking back over the past twelve months the stock has been a solid performer regardless, with a gain of 22%.

Following the heavy fall in price, EROAD may be sending buy signals at present with its price-to-sales (or "P/S") ratio of 1.1x, considering almost half of all companies in the Electronic industry in New Zealand have P/S ratios greater than 1.6x and even P/S higher than 8x aren't out of the ordinary. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's limited.

View our latest analysis for EROAD

ps-multiple-vs-industry
NZSE:ERD Price to Sales Ratio vs Industry December 12th 2025
Advertisement

What Does EROAD's P/S Mean For Shareholders?

EROAD could be doing better as it's been growing revenue less than most other companies lately. The P/S ratio is probably low because investors think this lacklustre revenue performance isn't going to get any better. If you still like the company, you'd be hoping revenue doesn't get any worse and that you could pick up some stock while it's out of favour.

Want the full picture on analyst estimates for the company? Then our free report on EROAD will help you uncover what's on the horizon.

What Are Revenue Growth Metrics Telling Us About The Low P/S?

The only time you'd be truly comfortable seeing a P/S as low as EROAD's is when the company's growth is on track to lag the industry.

Retrospectively, the last year delivered a decent 4.6% gain to the company's revenues. The latest three year period has also seen a 30% overall rise in revenue, aided somewhat by its short-term performance. Accordingly, shareholders would have probably been satisfied with the medium-term rates of revenue growth.

Shifting to the future, estimates from the four analysts covering the company suggest revenue should grow by 4.4% per annum over the next three years. That's shaping up to be materially lower than the 15% per annum growth forecast for the broader industry.

In light of this, it's understandable that EROAD's P/S sits below the majority of other companies. It seems most investors are expecting to see limited future growth and are only willing to pay a reduced amount for the stock.

What We Can Learn From EROAD's P/S?

EROAD's P/S has taken a dip along with its share price. Using the price-to-sales ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.

As we suspected, our examination of EROAD's analyst forecasts revealed that its inferior revenue outlook is contributing to its low P/S. At this stage investors feel the potential for an improvement in revenue isn't great enough to justify a higher P/S ratio. It's hard to see the share price rising strongly in the near future under these circumstances.

Before you settle on your opinion, we've discovered 2 warning signs for EROAD (1 is potentially serious!) that you should be aware of.

If strong companies turning a profit tickle your fancy, then you'll want to check out this free list of interesting companies that trade on a low P/E (but have proven they can grow earnings).

Valuation is complex, but we're here to simplify it.

Discover if EROAD might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NZSE:ERD

EROAD

Provides electronic on-board units and software as a service to the transport industry in New Zealand, the United States, and Australia.

Adequate balance sheet and slightly overvalued.

Similar Companies

Advertisement

Weekly Picks

DA
davidlsander
OPTH logo
davidlsander on Optimi Health ·

OPTH: A licensed manufacturer already selling MDMA while peers still wait on trials

Fair Value:US$1259.6% undervalued
11 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
HA
HarishPK
DOX logo
HarishPK on Amdocs ·

Why Amdocs is a high conviction Buy for me?

Fair Value:US$82.0328.6% undervalued
36 users have followed this narrative
3 users have commented on this narrative
12 users have liked this narrative
IV
SBMO logo
Ivoed on SBM Offshore ·

Why SBM Offshore’s €30 Share Price May Be Too Harsh On Its Backlog

Fair Value:€44.524.7% undervalued
23 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
CL
Clive_Thompson
6831 logo
Clive_Thompson on Green Tea Group ·

One of China's Fastest-Growing Restaurant Chains Trades on Just 7x Earnings and an 8% Dividend

Fair Value:HK$8.722.1% undervalued
48 users have followed this narrative
3 users have commented on this narrative
20 users have liked this narrative

Updated Narratives

RO
RockeTeller
STLR logo
RockeTeller on STLLR Gold ·

STLLR Gold, Eric Sprott + Agnico Backed: Massive Canadian Gold Developer at Junior Prices

Fair Value:CA$102.2298.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
PE
RYTM logo
peter_4mgsy on Rhythm Pharmaceuticals ·

High-Growth Emerging Commercial Stage Biotech

Fair Value:US$13413.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WO
woodworthfund
RAIL logo
woodworthfund on FreightCar America ·

ALL ABOARD THE VALUE TRAIN: WHY $RAIL MIGHT BE HEADED NORTH - FREIGHTCAR AMERICA - Long term price target of $25

Fair Value:US$2568.4% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.3% undervalued
288 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9120.5% overvalued
153 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0941.5% undervalued
173 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative